Back
Akero Therapeutics Vs. Gorman-Rupp Industry Stock Comparison
Sell
50
AKRO
Akero Therapeutics
Last Price:
22.03
Seasonality Move:
6.97%
Buy
68
GRC
Gorman-Rupp
Last Price:
32.92
Seasonality Move:
2.86%
Sell
50
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $22.13. The Score for AKRO is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- AKRO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
68
Gorman-Rupp (GRC)
is a Buy
Is Gorman-Rupp a Buy, Sell or Hold?
- The current Gorman-Rupp [GRC] share price is $32.79. The Score for GRC is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- GRC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $22.13
The current trend is relatively stagnant and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
GRC Stock Price Chart
What is Gorman-Rupp's stock price today?
-
The Gorman-Rupp share price today is $32.79
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GRC is experiencing selling pressure, which indicates risk of future bearish movement.
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.95 | Sell |
Relative Strength Index (14 RSI): | 53.45 | Buy |
Chaikin Money Flow: | 694389 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (19.96 - 22.74) | Buy |
Bollinger Bands (100): | (20.25 - 26.05) | Sell |
GRC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.3 | Sell |
Relative Strength Index (14 RSI): | 33.96 | Sell |
Chaikin Money Flow: | -91249 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.51 - 38.09) | Sell |
Bollinger Bands (100): | (33.66 - 37.68) | Sell |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 19.97 | Buy |
20-day SMA: | 20.9 | Buy |
50-day SMA: | 24.25 | Sell |
200-day SMA: | 28.08 | Sell |
8-day EMA: | 20.44 | Buy |
20-day EMA: | 21.1 | Buy |
50-day EMA: | 22.47 | Sell |
200-day EMA: | 27.02 | Sell |
GRC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.73 | Buy |
20-day SMA: | 35.11 | Sell |
50-day SMA: | 36.67 | Sell |
200-day SMA: | 33.59 | Sell |
8-day EMA: | 33.26 | Sell |
20-day EMA: | 34.68 | Sell |
50-day EMA: | 35.72 | Sell |
200-day EMA: | 33.65 | Sell |
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.19 per share, a decrease this year of $1.01 per share, and a decrease next year of $0.65 per share.
Gorman-Rupp Earnings Growth & GRC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.08 per share, an increase this year of $0.27 per share, and an increase next year of $0.32 per share.
Akero Therapeutics Technical Analysis
Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Gorman-Rupp Technical Analysis
Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |